Medico's board approved Q1 financial results. Revenue hit ₹69.40 Cr, with profit at ₹2.52 Cr. The board also re-appointed Rishit Mehta and Haresh Mehta as Whole-Time Directors and increased MD Harshit Mehta's remuneration.
Medico Remedies secured a government order worth ₹13.38 Cr from PROMESE/CAL, Dominican Republic. The contract involves supplying tablets, capsules, and dry syrups, with full execution expected within 3 months.
Medico Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
